HIVAging
Meeting category
Date(s)
10 Oct 2019 - 11 Oct 2019
2
Organizer
Platinum Level Support
Sponsor logos
ViiW
gilead

International Workshop on HIV & Aging 2019

Related Enduring Materials

Enduring Materials
Day 1 - Thursday, October 10th 2019
- 08:30
08:30 EST
Mentoring Breakfast and Table Discussions
Kevin High, MD, MS
Wake Forest Baptist Health, Winston-Salem, NC, United States
Session 1: HIV and aging then and now -
Chairs
Joseph Margolick, MD, PhD
Johns Hopkins Bloomberg School of Public Health, United States
Kristine Erlandson, MD, MS
University of Colorado Denver- Anschutz Medical Campus, United States
10:15 EST
10 Years of Aging Research: Frailty and Aging
Linda Fried, MD, MPH
Columbia University, New York, NY, United States
10:45 EST
Influences on future morbidity burden in adults with HIV
Keri Althoff, PhD, MPH
Johns Hopkins University, Bloomberg School of Public Health, United States
Abstract Session - 11:30
11:30 EST
Abstract-driven Presentations
Blunted increase in muscle mass after exercise training in people aging with HIV
Catherine Jankowski
University Of Colorado, USA
Food insecurity and frailty among women in the U.S.
Judy Tan
UCSF, USA
Impact of testosterone use on grip strength in men aging with HIV
Mary Clare Masters
Northwestern Memorial Hospital, USA
Session 2: Overlapping mechanisms driving HIV and aging -
Chairs
Russell Tracy, PhD
University of Vermont (UVM), United States
Julian Falutz, MD, FRCPC
McGill University, Canada
13:15 EST
Causation versus Correlation: the pathway of altered coagulation as a pathophysiological mechanism in HIV disease
Jason Baker, MD
University of Minnesota, United States
Abstract-Driven Presentations - 13:45
13:45 EST
Abstract-Driven Presentations
Epigenetic age acceleration and non-AIDS defining cancers among HIV infected adults
Chad Achenbach
Northwestern University, USA
Lipidome abnormalities and altered macrophage phenotype may contribute to cardiovascular disease risk in the aging HIV population
Emily Bowman
The Ohio State University, USA
Elevated cardiac risk score by ASCVD calculation is associated with albuminuria in older people living with HIV
Carrie Johnston
Nyp-weill Cornell Medical Center, USA
The association between mitochondrial DNA copy number and longitudinal lung function decline among people with or at risk of HIV
Jing Sun
Johns Hopkins Bloomberg School Of Public Health, USA
Session 3: HIV and aging: breaking down the walls -
Chairs
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Bruce Brew, MD
Committees - Virology Education
15:30 EST
HIV and aging in sub-Saharan Africa
Jean B. Nachega, MD, PhD, MPH, FRCP, FAAS
University of Pittsburgh / Johns Hopkins University, United States Stellenbosch University, South Africa
Abstract-Driven Presentations - 16:00
16:00 EST
Abstract-Driven Presentations
The aging of HIV epidemic in Ukraine: New HIV diagnoses from 2015-2018 and related mortality among adults ≥50 years
Julia Rozanova
Yale University School Of Medicine, USA
Frailty phenotype in older virologically suppressed PLWHIV is strongly correlated with specific comorbidities and tobacco use
Christina Psomas
European Hospital Marseille, France
Cellular and molecular assessment of muscle function as a predictor of ageing phenotype in older PLWH
Matthew Hunt
Newcastle University, UK

Day 2 - Friday, October 11th 2019

Session 4: Cannabis use among older adults with HIV -
Chairs
Scott Letendre, MD
University of California – San Diego, United States
Savita Pahwa, MD
University of Miami School of Medicine, United States
08:00 EST
Use of Cannabis: Basic Scientist's Perspective
Linda Chang, MD
University of Hawaii, HI, United States
08:30 EST
The promise, and challenge, of cannabis and cannabinoids as medicine
Thomas Marcotte, PhD
University of California San Diego, CA, United States
Session 5: It is so much more than the virus -
Chairs
David Moore, PhD
University of California – San Diego, United States
Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
10:30 EST
Loneliness/Social Isolation
Maile Karris, MD
University of California San Diego, United States
Abstract-Driven Presentations - 11:00
11:00 EST
Abstract-Driven Presentations
HIV infection does not increase the frequency of phosphorylated tau and beta amyloid in brain in late middle age
Susan Morgello
Icahn School Of Medicine At Mount Sinai, USA
Predictors of longitudinal neuropathic pain in older patients with HIV-associated distal sensory polyneuropathy
Monica Diaz
University Of California, USA
The utility of olfactory function in distinguishing early stage Alzheimer’s disease from HIV-associated neurocognitive disorder: a pilot study
Erin Sundermann
University Of California, USA
The structure and correlates of loneliness and social isolation among PLWH over 55 with mild neurocognitive disorder
Sarah Dobbins
UCSF School Of Nursing, USA
What is the lived experience of loneliness in older men living with HIV? A qualitative analysis to guide service development
Amanda Austin-Keiller
McGill University, Canada
Intrinsic capacity but not frailty predicts functional status in PLWH: a multi-centre prospective study
Giovanni Guaraldi
Metabolic Clinic, University Of Modena And Reggio Emilia, Italy
Session 6: Is an HIV cure what older adults with HIV really want? What can we apply to aging, and how can we best advocate for those aging with HIV -
Chairs
Alan Landay, PhD
Rush University Medical Center, United States
Maile Karris, MD
University of California San Diego, United States
13:30 EST
HIV cure research in an aging population: unique opportunities and challenges
Steven Deeks, MD
University of California, San Francisco, United States
14:00 EST
Being a researcher and community advocate in HIV and aging
Speaker to be confirmed
-
Stephen Karpiak, PhD
ACRIA Center of HIV & Aging, United States
14:45 EST
Closing of the Workshop
Overview
Welcome

Over 140 participants attended the 10th edition of the International Workshop on HIV & Aging at the New Yorker Hotel in New York, NY, USA. We would like to thank everybody for their invaluable contribution in making this workshop such a success.

On behalf of the Organizing Committee, we would also like to express our gratitude to ViiV Healthcare, Gilead, Janssen and Merck for their generous support. 

Presentations and webcasts from the 2019 edition (provided that the speaker's consent has been received) are available on this website. 

We look forward to seeing you again at the next edition of this workshop. 

Committees

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts. 

Organizing Committee
Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Beau Ances, MD, Washington University in St. Louis, United States

  • Bruce Brew, MD, St. Vincent's Hospital, Australia

  • Daniel Duprez, MD, University of Minnesota, United States

  • Meredith Greene, MD, University of California, San Francisco, United States

  • Steven Grinspoon, MD, Massachusetts General Hospital, United States

  • Marica Holstad, PhD, Emory University, Atlanta, Georgia, United States

  • Amy Justice, MD, PhD, Yale School of Public Health, United States

  • Jordan Lake, MD, MSc, UTHealth, United States

  • Alan Landay, PhD, Rush University Medical Center, United States

  • Michael Lederman, MD, Case Western Reserve University, United States

  • Avindra Nath, MD, National Institutes of Health, United States

  • Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona, Spain

  • Molly Perkins, PhD, Emory University, Atlanta, Georgia, United States

  • Sean Rourke, PhD, University of Toronto, Canada

  • Victor Valcour, MD, University of California, San Francisco, United States

  • Cara Wilson, MD, University of Colorado, United States

Support
Contributor Level
Language